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Abstract
Background: The incidence of reported adolescent and adult pertussis continues to rise in the
United States. Acellular pertussis vaccines for adolescents and adults have been developed and may
be available soon for use in the U.S. Our objectives were: (1) to describe patient valuations of
pertussis disease and vaccination; and (2) to compare valuations for short-term and long-term
health states associated with pertussis.
Methods: We conducted telephone surveys with 515 adult patients and parents of adolescent
patients with pertussis in Massachusetts to determine valuations of pertussis-related health states
for disease and vaccination using time trade-off (TTO) and contingent valuation (CV) techniques.
Respondents were randomized to complete either a short-term or long-term TTO exercise.
Discrimination between health states for each valuation technique was assessed using Tukey's
method, and valuations for short-term vs. long-term health states were compared using the
Wilcoxon rank-sum test.
Results: Three hundred three (59%) and 309 (60%) respondents completed and understood the
TTO and CV exercises, respectively. Overall, respondents gave lower valuations (lower TTO and
higher CV values) to avoid a given state for adolescent/adult disease compared to vaccine adverse
events. Infant complications due to pertussis were considered worse than adolescent/adult disease,
regardless of the method of valuation. The short-term TTO resulted in lower mean valuations and
larger mean differences between health states than the long-term TTO exercise.
Conclusion: Pertussis was considered worse than adverse events due to vaccination. Short-term
health-state valuation is better able to discriminate among health states, which is useful for cost-
utility analysis.
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Background
The incidence of reported pertussis continues to rise in the
United States despite high levels of childhood vaccination
[1,2]. Waning immunity is thought to contribute to the
particularly steep rise seen among adolescents and adults
over the past two decades [3,4]. Acellular pertussis booster
vaccines have been developed already and recommended
for use in several other countries including Canada,
France, Germany, and Australia [5-7]. A combined
booster (TdaP) also may become available soon for use in
the U.S.
Recently completed clinical trials suggest that the booster
may prevent cough illness related to pertussis among ado-
lescents and adults [8,9]. Though such illness does not
result in mortality in this age group, it can be prolonged
and associated with significant complications such as
pneumonia or urinary incontinence [10,11]. However,
implementation of a vaccination program for adolescents
and/or adults would carry a significant cost. Policymakers
will need to decide whether or not to recommend use of a
vaccine where the health benefits to adolescents and
adults are reductions in short-term morbidity, rather than
mortality, and the health risks include adverse events
from vaccination. Thus, further information regarding the
relative valuations by patients of different potential conse-
quences should be considered. Quantifying patient pref-
erences is relevant to decisions about allocation of limited
resources and is needed to assess the cost-effectiveness of
vaccination in comparison to other well-accepted health
interventions [12].
Methods commonly used for measuring health-state valu-
ations include contingent valuation (CV) and time trade-
off (TTO) [13]. Contingent valuation is an economic
approach to valuing different outcomes using monetary
value (e.g. willingness-to-pay, WTP) as a common metric;
for example, the relative amounts that individuals would
pay to avoid one health state or another may be inter-
preted as measures of their strength of preferences for time
spent in these different states. An advantage to this
approach is that respondents may find it relatively easy to
value short-term health states in monetary terms since
they are accustomed to assessing the dollar value of goods
and services in everyday transactions. However, some out-
comes are difficult to quantify using contingent valuation,
e.g. how much a person is willing to pay to avoid death.
Additionally, CV may be subject to anchoring effects and
income effects [14].
Another common approach to measuring the benefits and
harms of health interventions relies on health-state utili-
ties. Utilities measure a person's preferences for specific
outcomes on a scale of 0 to 1, on which 0 typically repre-
sents a state equivalent to death while 1 represents the
best imaginable health. The time trade-off method is one
of several approaches used to assess health utilities. Using
the TTO method, respondents are asked how much lon-
gevity they would be willing to give up, if any, to avoid liv-
ing with a particular health outcome. Traditionally, TTO
questions have been framed as giving up time to avoid a
long-term or chronic health state [15]. However, for many
common health problems, including those caused by
infections, the duration of the relevant health states is lim-
ited, not permanent. A more realistic approach would be
to frame these conditions as short-term health states.
We conducted a survey using TTO and CV methods to
determine the health-state valuations of adult patients
and parents of adolescent patients diagnosed with pertus-
sis. We compared two alternative approaches to framing
TTO questions, based on either short-term or long-term
health states. We hypothesized that framing questions as
short-term rather than as long-term health outcomes
would allow for better discrimination between states.
Methods
Study participants
Structured telephone interviews were conducted with
adult patients (≥  18 years) and parents of adolescent
patients (11–17 years) diagnosed with confirmed pertus-
sis in Massachusetts from December 1, 2001 to January
31, 2003 [11]. There were 800 cases of confirmed pertus-
sis among adolescents and adults during this time period,
and 517 (65%) respondents completed the telephone
interviews, although two were excluded because the
wrong health-state valuation survey was administered.
Interviews included questions about medical and non-
medical costs of illness and questions regarding health-
state valuations for pertussis disease and vaccination.
There were no significant differences in age, gender or
race/ethnicity between respondents and all confirmed
cases during the enrollment period. The study was
reviewed and approved by the Institutional Review Boards
of Children's Hospital Boston, Harvard Pilgrim Health
Care, Massachusetts Department of Public Health, and
Centers for Disease Control and Prevention.
Survey protocol
Descriptions of the health states were derived with input
from 3 pertussis experts (Table 1). Adults were asked ques-
tions about themselves while parents were asked to
respond in reference to outcomes in their adolescents. We
also asked both adults and parents of adolescents to value
the prevention of infant health states (respiratory compli-
cations, neurologic complications) due to pertussis. All
surveys included open-ended TTO and CV questions; in
other words, respondents were asked once about the max-
imum amount of longevity they would give up, or the
maximum amount of money they would be willing toHealth and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
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pay, to avoid the health outcome in question. We chose
the open-ended format [16-19] due to the large number
of items evaluated and for ease of administration by tele-
phone. Additionally, prior methodologic work on open-
ended CV techniques has demonstrated similar results to
the commonly used but more intensive alternative involv-
ing dichotomous-choice questions.[18]
For TTO questions, respondents were asked the maximum
amount of time they would be willing to trade from the
end of their lives to avoid a particular health outcome
now. Adults were asked how much time they would give
up from the end of their lives to avoid living in a particular
health state themselves, while parents were asked how
much time they would give up from the end of their own
lives to avert the health state in the adolescent [17,20].
This approach was adopted after pre-testing the survey
instrument with parents, who were more willing to
answer questions about trading time from their own lives
than from their children's lives. For infant health states,
both sets of respondents were asked to give up time from
the ends of their own lives to avoid a long-term or short-
term health state in an infant.
Although TTO questions traditionally have been framed
using permanent health states for valuations of chronic
disease [15], the health states associated with pertussis
and vaccination are limited, lasting anywhere from days
to weeks. Thus, asking respondents to imagine that they
had to live for the rest of their lives with an infection or
vaccine adverse event is not realistic. In order to address
this concern and to test the hypothesis that framing the
question as a short-term health state would significantly
alter the TTO response, we created 2 versions of the survey
– one with short-term and one with long-term (perma-
nent) health states. Long-term health states were
described as lasting for the lifetime of the infant, adoles-
cent, or adult. Short-term health states were described as
lasting for a duration of 8 weeks for the infant, adolescent
or adult. We chose a constant duration for the short-term
health states to ensure consistent responses regarding rank
order and comparability of health states. In order to deter-
mine which version of the survey the parent or adult
would receive, we used a random number generator to
assign interviews to respondents once they consented to
participate in the study.
CV questions elicited the amount of money that a
respondent would be willing to pay to avoid living in a
particular health state for 8 weeks. We chose to frame the
CV questions as short-term health states for both versions
of the survey based on prior work [21,22]. Respondents
were instructed not to consider any money lost from
missed work or any co-payments that would be required.
Telephone interviews were conducted in English or Span-
ish using standardized forms. Some respondents either
were unable to complete or refused to answer the entire
set of TTO questions or CV questions. If any answers were
missing within a set of questions, respondents were
excluded from analyses (of that set) in order to assess pop-
ulation means. If the respondent completed either set of
questions, trained interviewers judged how well the
respondent understood the TTO or CV questions sepa-
rately based on a 3-point scale (good understanding,
some understanding, limited understanding). Respond-
ents were excluded from further analyses if they were
thought to have either some or limited understanding of
the tasks presented [23].
Calculation of utilities – long-term states
We calculated utilities based on the TTO exercise, under
alternative assumptions about discounting of future
health outcomes. For long-term health states, the utility
Table 1: Health-state descriptions for outcomes associated with disease and vaccination.
Health states Description
Local reaction A sore upper arm that is slightly red, swollen, and tender after receiving a vaccination
Systemic Reaction Low-grade fevers, headache, body ache, and decreased energy after receiving a vaccination
Mild cough Coughing attacks that last for 1–2 minutes at a time and occur up to 8–10×/day. These coughing attacks wake 
you up at night several times a week, but you otherwise feel well between coughing attacks.
Severe cough A cough that is so frequent and severe that it causes vomiting at least several times a week, difficulty eating or 
drinking, and difficulty sleeping every night.
Pneumonia A severe cough with high fevers, chills, fatigue, and shortness of breath
Respiratory complications 
(apnea and cyanosis)
A 1-month-old baby that has coughing episodes so hard that he/she stops breathing and turns blue for 10–15 
seconds. These episodes happen 8 to 10 times a day and the baby needs to be hospitalized, but is completely 
healthy afterwards.
Neurologic complications 
(seizures and encephalopathy)
A 1-month-old baby with seizures or convulsions. The seizures cause brief periods of being unconscious and the 
baby's arms and legs shake. They can last for up to 5 minutes at a time and happen several times a day. The baby 
needs to be hospitalized, but is completely healthy afterwards.Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
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was based on the proportion of time that the respondent
would be willing to give up to avoid a lifetime health state
for themselves, for their adolescent child, or for a hypo-
thetical infant (Figure 1). Life expectancy (LE) was calcu-
lated using age- and sex-specific cohort life tables [24]. In
the cases of adolescents and infants, since the time given
up would come from the adult respondent's lifespan,
while the healthy time gained would accrue to the adoles-
cent or infant, the computations required LE estimates for
both the respondent and the beneficiary in the trade-off.
It is most straightforward computationally to start with
the disutility, rather than the utility, of a particular health
state, computed as the ratio of the duration of life that
would be given up (to avoid the lifetime health state) to
the expected duration of time lived in the health state. In
the absence of discounting, the disutility was calculated
simply by dividing the amount of time traded from the
end of the respondent's life by the LE of the beneficiary.
The utility was then calculated by subtracting this result
from one. With discounting, we assumed that individuals
compared the present values of the two different streams
of life in the trade-off, in a way that reflects declining rel-
ative weight for future consequences, and we computed
utilities based on a discount rate (r) of 3% per year [12].
As empirical studies on time preference have reported a
range of discount rates [25-27], we also examined the sen-
sitivity of our findings to alternative assumptions about
discounting, including discount rates of 5% and 10% (as
well as the 0% rate implied by the no-discounting case).
Conceptual model for calculating utilities for long-term and short-term health states for adults and adolescents or infants Figure 1
Conceptual model for calculating utilities for long-term and short-term health states for adults and adolescents or infants. In 
each of the four panels, the top bar indicates the amount of longevity that is given up from the end of the respondent's life in 
each of the trade-offs, and the bottom bar indicates the averted duration of time in a given health state. Abbreviations: TTO, 
time trade-off; LE, life expectancy.
Time traded 
from end of life 
Adult LE  Adult age 
Long-term health state in adult
Adult age  Adult LE 
Time traded from end 
of respondent life 
Respondent  
age 
Respondent  
LE
Long-term health state in adolescent / infant
Adolescent /
infant age 
Adolescent /
infant LE 
Time traded 
from end of life 
Adult LE  Adult age 
Short-term health state in adult
Adult age  Adult LE 
Time traded from end 
of respondent life 
Respondent  
age 
Respondent  
LE
Short-term health state in adolescent / infant
Adolescent /
infant age 
Adolescent /
infant LE 
Short-term
TTO
Long-term
TTO
 Adults         Adolescents or infants 
          
           Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
Page 5 of 14
(page number not for citation purposes)
Using the formula for discounting a continuous stream of
life [28], we obtained the present value of future time
traded from the end of life (the numerator in the disutility
calculation) by taking the difference between the dis-
counted stream of normal life expectancy for the respond-
ent and the discounted stream of shortened life
expectancy:
(1/r) * (1 - e-r (LE of respondent)) - (1/r) * (1 - e-r (LE of respondent
- years of life traded))
The present value of the current life expectancy for the
beneficiary (the denominator) was
(1/r) * (1 - e-r (LE of beneficiary))
The disutility for a given health state was computed as the
ratio of the two quantities, as in the undiscounted case,
and the utility was computed by subtracting the ratio from
one. For adult valuations, the respondent and beneficiary
were the same. For parents of adolescents or for respond-
ents considering a hypothetical infant, the numerator was
based on years traded from the respondent's life, while the
denominator was based on the life expectancy of the ado-
lescent or infant.
Calculation of utilities – short-term states
Utilities were calculated for the short-term health states in
an analogous fashion, except that time from the end of the
life of the respondent was traded to avoid 8 weeks of ill-
ness in the present time for the respondent, for the adoles-
cent child, or for a hypothetical infant (Figure 1). The
numerator was calculated in the same way as for the long-
term states, assuming a 3% discount rate in the baseline
analysis (and alternatives in sensitivity analysis):
(1/r) * (1 - e-r (LE of respondent)) - (1/r) * (1 - e-r (LE of respondent
- years of life traded))
For the denominator, discounting would have minimal
impact because the duration considered is only 8 weeks
and begins at the present, but we nevertheless converted
this duration to its present value for consistency:
(1/r) * (1 - e-r (8/52))
Again, the disutility was the ratio of these two quantities,
and the utility was computed by subtracting the ratio from
one.
Statistical analysis
Utilities and WTP values are presented as means (with
standard deviations) and medians (with interquartile
ranges). We assumed that the maximum amount of dis-
counted time traded from the end of the respondent's life
could not exceed the duration of the present health state;
thus, any utilities that would be negative based on the
computations described above were instead set to 0. For
parent respondents who were asked questions about how
much time they would trade to avoid long-term health
states in their adolescents, we used interval regression
with left censoring to calculate mean utilities [29]. In
interval regression, when parents were willing to trade off
their full life expectancy to avoid a lifetime health out-
come in their child, we treated this observation as provid-
ing only partial information about the amount that
parents would give up, since they were limited by their life
span – which was always shorter than the lifespan of the
beneficiary adolescent. These observations were assumed
to indicate a range of time spanning between the longevity
of the parent and that of the adolescent. Interval regres-
sion was used to limit bias as a result of this constraint.
When parents traded-off less than their full life expect-
ancy, interval regression was equivalent to ordinary least
squares regression. For infant health states, an analogous
approach based on interval regression was applied.
To compare demographic characteristics of respondents
for the short-term vs. long-term TTO surveys, we used the
chi-squared test for categorical variables and the t-test for
continuous variables. To determine if mean health state
utilities and WTP values were significantly different from
one another, we used Tukey's method, which is a non-par-
ametric test that allows for multiple pairwise comparisons
assuming all sample sizes are equal [30] Comparison of
utilities for short-term vs. long-term health states was per-
formed using the Wilcoxon rank sum test based on 2 inde-
pendent samples [30]. Spearman rank correlation was
used to determine associations between demographic
characteristics and TTO or CV responses [30]. A p-value of
<0.05 was considered statistically significant.
Results
Respondent characteristics
Five hundred fifteen adult pertussis patients and parents
of adolescent pertussis patients were eligible and
participated in the survey (Figure 2). Characteristics of the
respondents are described in Table 2. There were no sig-
nificant differences between respondents who received
either form of the survey. Overall, 303 (59%) respondents
completed and understood the TTO portion of the survey
and 309 (60%) respondents completed and understood
the CV portion of the survey. When response rates of par-
ents and adults were compared, we found no significant
differences in response rates to the short-term TTO ques-
tions (p = 0.28); however, adults were significantly more
likely to respond than parents of adolescents to the long-
term TTO questions (p = 0.006). Other respondents were
not included for analysis because: (1) the TTO (27%) or
CV (22%) survey was not completed by respondents; orHealth and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
Page 6 of 14
(page number not for citation purposes)
(2) one or more answers within a set of TTO (9%) or CV
(12%) questions were not completed; or (3) respondents
completed but were thought not to understand the TTO
(6%) or CV (5%) exercise.
We compared demographic characteristics of respondents
who completed and understood the survey with those
who did not. Parents of adolescents with higher house-
hold incomes (p = 0.022) and higher educational levels
(p= 0.017) were more likely to complete and understand
the CV survey. Also, parents who were white (p = 0.011)
with higher educational levels (p = 0.010) were more
likely to complete and understand the TTO survey. Adult
respondents who completed and understood the CV and
TTO survey were significantly younger (p = 0.006 for CV;
p = 0.025 for TTO) and had higher educational levels (p =
0.005 for CV; p = 0.012 for TTO) than those who did not.
Adolescent health states
CV and TTO responses for short-term and long-term
health states for adolescents are described in Table 3.
Based on mean utilities, parents of adolescents ranked the
following long-term health states from best to worst: local
reaction, systemic reaction, mild cough, severe cough, and
pneumonia. Short-term health state rankings were simi-
lar, except mean utilities for severe cough and pneumonia
were equivalent. For both short-term and long-term
health states (Figure 3), we found significant differences
in mean utilities (zero not included in the confidence
interval) for most pairwise comparisons (Tukey's method,
p<0.05). However, the mean utilities for health states that
ranked close to each other were not significantly different,
such as local reaction vs. systemic reaction, systemic reac-
tion vs. mild cough, and severe cough vs. pneumonia. CV
responses reflected rankings similar to TTO responses for
parent respondents (Table 3). However, there were no sig-
nificant differences between the amounts individuals
were willing to pay to avoid adolescent health states.
Study enrollment Figure 2
Study enrollment. Percentages indicate proportion of respondents who were given the survey that completed the entire set of 
questions and understood the TTO and WTP exercises. Abbreviations: TTO, time trade-off; WTP, willingness to pay.
517 adults and parents of 
adolescents interviewed 
515 considered eligible
WTP and short-term TTO 
survey administered to
267 adults and parents 
WTP and long-term TTO 
survey administered to
248 adults and parents
158 parents  165 parents  109 adults  83 adults 
94/158  (59%) 
completed & 
understood TTO 
72/109 (66%) 
completed & 
understood TTO 
81/165 (49%) 
completed & 
understood TTO 
56/83 (67%) 
completed & 
understood TTO 
100/158 (63%) 
completed & 
understood WTP 
67/109 (61%) 
completed & 
understood WTP 
83/165 (50%) 
completed & 
understood WTP 
59/83 (71%) 
completed & 
understood WTP Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
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Table 2: Characteristics of respondents interviewed using short-term TTO (N = 267) vs. long-term TTO (N = 248).*
Characteristics Short-term TTO Long-term TTO P-value
Mean age of respondent [range]** 42.4 [18–87] 41.7 [18–81] 0.49
Gender of respondent
Female 207 (78%) 205 (83%) 0.35
Male 56 (21%) 40 (16%)
Not available 4 (2%) 3 (1%)
Race/ethnicity of respondent:
White 238 (89%) 219 (88%) 0.67
Black 7 (3%) 4 (2%)
Hispanic 11 (4%) 15 (6%)
Other or unknown 11 (4%) 10 (4%)
Educational level of respondent:
Up to high school 67 (25%) 52 (21%) 0.48
Up to college or technical 
school
136 (51%) 143 (58%)
>College 60 (22%) 49 (20%)
Refused to answer 4 (2%) 4 (2%)
Annual household income:
<$20,000 28 (10%) 26 (10%) 0.79
$20,000–49,999 55 (21%) 53 (21%)
$50,000–79,999 52 (19%) 58 (23%)
≥  $80,000 98 (37%) 80 (32%)
Refused to answer 34 (13%) 31 (13%)
*Numbers may not add up to 100% due to rounding
**Missing ages for 8 parents of adolescents
Table 3: Adolescent Pertussis – days or years traded, utilities, and willingness-to-pay to avoid health states
Vaccination health states Disease health states
Local reaction Systemic reaction Mild cough Severe cough Pneumonia
Short-term TTO (N = 94)
Days traded
Mean (SD) 17 (46) 29 (61) 55 (117) 90 (162) 79 (114)
Median [25%–75%] 2 [0–14] 7 [2–28] 25 [7–56] 45 [14–56] 41 [14–70]
Utilities*
Mean (SD) 0.92 (0.19) 0.86 (0.23) 0.78 (0.27) 0.67 (0.33) 0.67 (0.33)
Median [25%–75%] 0.99 [0.93–1.0] 0.96 [0.85–0.99] 0.87 [0.72–0.96] 0.78 [0.61–0.92] 0.78 [0.61–0.91]
Long-term TTO (N = 81)
Years traded
Mean (SD) 2.6 (4.1) 5.5 (5.9) 8.0 (6.7) 11.6 (9.0) 12.0 (9.5)
Median [25%–75%] 1 [0.1–5] 5 [1–5] 5 [5–10] 10 [5–20] 10 [5–20]
Utilities*
Mean (SD) 0.97 (0.07) 0.93 (0.10) 0.89 (0.12) 0.83 (0.17) 0.82 (0.17)
Median [25%–75%] 0.99 [0.96–1.0] 0.95 [0.92–0.99] 0.93 [0.87–0.95] 0.88 [0.78–0.94] 0.88 [0.76–0.94]
Willingness-to-pay (N = 183)
Mean (SD) $18 (58) $61 (174) $3,003 (15,889) $3,981 (16,797) $4,265 (16,860)
Median [25%–75%] $3 [1–13] $13 [6–38] $300 [150–1,500] $750 [225–1,500] $750 [263–1,500]
*Utilities were calculated assuming the maximum amount of time traded could not exceed the duration of the health state in the adolescent and 
assuming a discount rate of 3%.Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
Page 8 of 14
(page number not for citation purposes)
Adult health states
Short-term and long-term TTO responses for adult
respondents are described in Table 4. Based on mean util-
ities, adults ranked short-term health states in the follow-
ing order: local reaction, systemic reaction, mild cough,
pneumonia, and severe cough. Mean rankings for long-
term health states were similar, except pneumonia and
severe cough were equivalent. For short-term health states
(Figure 4), mean differences in utilities were significantly
different for 5 out of 10 pairwise comparisons (Tukey's
method, p < 0.05). However, the only significant differ-
ences in utilities for long-term health states were: local
reaction vs. severe cough, local reaction vs. pneumonia,
systemic reaction vs. severe cough, and systemic reaction
vs. pneumonia (Tukey's method, p < 0.05). CV responses
again reflected a rank order similar to the TTO exercise
(Table 4). We were unable to detect significant pairwise
differences in the WTP amounts to avoid adult health
states.
Infant health states
TTO and CV responses for infant health states are
described in Table 5. We asked all respondents to imagine
they had a 1-month-old infant who developed pertussis
that could result in either short-term (8 weeks followed by
perfect health) or long-term health states. Mean utilities
for short-term infant health states, such as respiratory or
neurologic complications due to pertussis, were lower
than mean utilities for vaccine adverse events or adoles-
cent/adult disease. However, mean utilities for long-term
infant health states were not significantly different from
adolescent/adult disease utilities. All respondents were
Mean difference between TTO utilities and 95% confidence intervals for short-term (squares) and long-term (circles) health  states for adolescents Figure 3
Mean difference between TTO utilities and 95% confidence intervals for short-term (squares) and long-term (circles) health 
states for adolescents.
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willing to pay significantly more to avoid infant disease
compared to vaccine adverse events or adolescent/adult
disease. Neurologic disease was considered significantly
worse than infant respiratory disease regardless of the
method of valuation.
Comparison of utilities for short-term vs. long-term health 
states
Overall, mean utilities were higher for long-term health
states than for short-term health states. These differences
were significant for adolescents with mild cough (p =
0.045), severe cough (p = 0.001), and pneumonia (p =
0.001). No significant differences were found between
short-term and long-term health states for adults. For
infants, we also found significant differences with higher
mean utilities reported for long-term health states com-
pared to short-term health states (p < 0.001 for respiratory
complications; p < 0.001 for neurologic complications).
Association between demographic variables and TTO or 
WTP estimates
We evaluated associations between demographic charac-
teristics such as age, race/ethnicity, education, and house-
hold income and estimates provided by respondents for
the TTO or CV exercise. Older age was associated with
lower utilities for short-term health states for adolescent/
adult disease (i.e. mild cough, severe cough, pneumonia)
and infant disease (i.e. respiratory and neurologic compli-
cations) (p < 0.05). Older age was also associated with
lower utilities for long-term health states such as systemic
reaction, adolescent/adult disease, and infant disease (p <
0.05). Higher income was associated with lower utilities
for long-term mild cough and short-term respiratory com-
plications, although older respondents were more likely
to report higher household incomes (p < 0.001).
Higher income was significantly associated with higher
WTP values for the following health states: systemic reac-
tion, adolescent/adult disease, and infant disease (p <
0.05). We also found an association between higher
respondent education and higher WTP estimates for
pneumonia, although we note that education and income
were themselves positively correlated (ρ  = 0.358, p <
0.0001).
Alternative assumptions about the discount rate
Tables 6A and 6B describe estimated mean utilities for
short-term and long-term health states associated with
disease and vaccination in adolescents, adults, and
infants. At higher discount rates, the mean differences
between utilities for different health states became
smaller, regardless of age group or method of valuation.
Discussion
Vaccination programs in the US have traditionally been
life-saving and cost-saving [31,32]. However, the focus of
newer vaccines being developed has shifted from prevent-
ing mortality to preventing morbidity. In this situation,
the risks of vaccine adverse events need to be weighed
carefully against their benefits. Health-state valuation
studies are useful to assess the relative risks and benefits of
potential future vaccination programs under considera-
Table 4: Adult pertussis – days or years traded, utilities and willingness-to-pay to avoid health states
Vaccination health states Disease health states
Local reaction Systemic reaction Mild cough Severe cough Pneumonia
Short-term TTO (N = 72)
Days traded
Mean (SD) 24 (135) 26 (130) 80 (366) 99 (446) 101 (448)
Median [25%–75%] 0 [0–2] 2.5 [0–7] 8.5 [0.5–28] 14 [2–56] 14 [2–49]
Utilities*
Mean (SD) 0.95 (0.18) 0.93 (0.18) 0.85 (0.26) 0.81 (0.30) 0.82 (0.30)
Median [25%–75%] 1.0 [0.99–1.0] 0.99 [0.95–1.0] 0.96 [0.88–1.0] 0.95 [0.81–0.99] 0.96 [0.83–0.99]
Long-term TTO (N = 56)
Years traded
Mean (SD) 0.4 (0.8) 1.4 (2.2) 2.7 (3.4) 4.7 (6.3) 4.7 (6.2)
Median [25%–75%] 0.03 [0–0.9] 0.8 [0.04–1.5] 1 [0.6–4.5] 2 [1–5] 2 [0.8–5]
Utilities*
Mean (SD) 0.995 (0.01) 0.98 (0.03) 0.96 (0.06) 0.92 (0.14) 0.92 (0.16)
Median [25%–75%] 1.0 [0.99–1.0] 0.99 [0.98–1.0] 0.99 [0.96–1.0] 0.97 [0.92–0.99] 0.97 [0.91–0.99]
Willingness-to-pay (N = 126)
Mean (SD) $8 (17) $41 (78) $3,249 (14,062) $4,141 (15,409) $8,748 (66,907)
Median [25%–75%] $3 [0–9] $13 [6–38] $450 [150–1,200] $750 [300–1,500] $750 [300–1,500]
*Utilities were calculated assuming the maximum amount of time traded could not exceed the duration of the health state in the adult and assuming 
a discount rate of 3%.Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
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tion in the US. Our study examined valuations associated
with adolescent/adult pertussis disease and vaccination.
Overall, respondents rated adolescent and adult pertussis
as worse than vaccine adverse events. Also, infant compli-
cations due to pertussis were ranked as worse than adoles-
cent/adult disease.
We explored differences in utilities for short-term and
long-term health states using open-ended TTO questions.
Other methods for short-term health state valuation
described in the literature include chained TTO, sleep
tradeoff (STO), and waiting tradeoff (WTO). The chained
TTO has been shown to have good consistency and relia-
bility [13,33,34]. However, the chained procedure
involves an extra step and may result in a significant cog-
nitive burden due to the complexity of the task. The sleep
tradeoff asks people how much time they would be will-
ing to sleep in a non-refreshing/non-dream state to avoid
living with a short-term health problem [35,36]. Unfortu-
nately, this method may not be appropriate for valuing
health states associated with pertussis since sleep distur-
bance occurs in a majority of infected individuals, which
may confound responses regarding sleep [11]. The waiting
tradeoff proposed by Swan et al. is an alternative approach
for assessing process utility [37]. While this approach is
clearly useful for situations that involve diagnostic proce-
dures, its applicability to other short-term health states
such as infections is limited. We felt the open-ended for-
mat was the most appropriate method for our study pop-
ulation given the limitations of alternatives and due to
improved ease of administration by telephone.
Mean difference between TTO utilities and 95% confidence intervals for short-term (squares) and long-term (circles) health  states for adults Figure 4
Mean difference between TTO utilities and 95% confidence intervals for short-term (squares) and long-term (circles) health 
states for adults.
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We found that the rankings of health states based on
mean utilities were essentially the same using either short-
term or long-term health states. However, the short-term
TTO resulted in lower mean utility estimates and larger
mean differences between health states than the long-
term TTO exercise, thus allowing for better discrimination
of health states in cost-utility analyses. These results sug-
gest that responses may not fulfill the constant propor-
tional trade-off assumption, which requires that the TTO
utility be independent of the duration of the specified
health state. While previous studies using TTO and other
valuation methods have also found that the constant pro-
portional trade-off assumption does not always hold, the
direction of the discrepancy has been mixed [38-40].
The short-term health state approach may have violated
the constant proportional trade-off assumption because
respondents were less averse to giving up small amounts
of time from the ends of their lives (days or weeks) com-
pared to large amounts of time (months or years) in the
long-term approach. In other words, asking respondents
to give up a few days or weeks from the ends of their lives
may not be considered a significant loss, even to avoid a
short-duration health state lasting only 8 weeks. However,
giving up months or years of life is considerably more dif-
ficult for individuals, even to avoid an intermediate- or
long-term health state. It may be that a threshold exists
whereby individuals are more willing to give up a very
small portion of their lives for perfect health, but as the
duration of health states increase, they are less willing to
give up time per health unit gained, resulting in failure to
behave according to the constant proportional trade-off
assumption. This aversion to giving up larger amounts of
time may play an important role in measuring utilities,
particularly since the short duration of these health states
over the lifetime of individuals would otherwise lead to
nearly imperceptible, but arguably important differences
in terms of quality-adjusted life years.
The impact of discounting is important to consider since
assuming no discounting can lead to a downward bias,
while a high discount rate can lead to an upward bias,
which may strongly devalue the benefits of any preventive
intervention [12,41-43]. We assumed a 3% discount rate
in our baseline analysis, though there is no clear standard
regarding the optimal discount rate for societal decisions.
We also examined the implications of varying the dis-
count rate between 0 and 10%. If we assumed no dis-
counting of health preferences over time, the mean
utilities for all health states were lower and spread over a
wider range. At a discount rate of 10%, the mean values
for all health states approached 1.0 and mean differences
between health states were much smaller. Further empiri-
cal investigation of societal discount rates for prevention
programs is needed.
The CV exercise resulted in similar mean health state rank-
ings to our TTO exercise, and these estimates were posi-
tively correlated with income, which is not surprising
since individuals were asked to respond in consideration
Table 5: Infant pertussis – days or years traded, utilities, and willingness-to-pay to avoid health states*
Infant health states
Infant respiratory complications Infant neurologic complications
Short-term TTO (N = 166)
Days traded
Mean (SD) 174 (360) 226 (431)
Median [25%–75%] 56 [28–168] 56 [28–183]
Utilities
Mean (SD) 0.58 (0.37) 0.51 (0.38)
Median [25%–75%] 0.72 [0.10–0.88] 0.64 [0.0–0.85]
Long-term TTO (N = 137)
Years traded
Mean (SD) 12.3 (10.9) 15.2 (12.3)
Median [25%–75%] 10 [5–20] 10 [5–20]
Utilities**
Mean (SD) 0.82 (0.21) 0.77 (0.25)
Median [25%–75%] 0.89 [0.75–0.96] 0.87 [0.69–0.95]
Willingness-to-pay (N = 309)
Mean (SD) $13,016 (52,443) $19,426 (61,074)
Median [25%–75%] $1,500 [750–7,500] $3,000 [750–10,000]
*Responses from adults and parents of adolescents were pooled.
**Utilities were calculated assuming the maximum amount of time traded could not exceed the duration of the health state assuming a discount 
rate of 3%.Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
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of their actual household income [44]. For the TTO, we
found an inverse association between age and utility esti-
mates. This finding is consistent with previous studies that
have shown older individuals provide lower utility
estimates for health states [45,46]. It may be that
increased awareness of the reality of living in poor health
is better understood by older respondents [46].
As always, there are limitations to our study. First, our
respondents were either adult pertussis patients or parents
of adolescents with pertussis. We elicited patient and car-
egiver valuations as part of a larger study to determine
societal costs of pertussis in adolescents and adults. While
the U.S. Panel on Cost-effectiveness in Health and
Medicine suggests that community preferences be used
where possible[12], there is ongoing debate over whose
preferences should be included in cost-effectiveness anal-
yses.[47] There are certain practical advantages to survey-
ing patients and caregivers. Because these individuals had
recent first-hand experience with the disease, reasonably
short descriptions could be used to sufficiently
characterize a series of health states associated with per-
tussis, making administration by telephone feasible.
While there is no perfect measure of health, patient pref-
erences can help to inform societal values and should be
given further consideration. If community valuations are
collected in subsequent studies, it will be useful to com-
pare them to the patient and caregiver valuations collected
here.
Second, selection bias might arise from our survey com-
pletion rate of around 60%, although this is comparable
to other published valuation studies [20,23]. In our study,
a significant proportion of respondents did not complete
Table 6: Utilities based on alternative discount rates of 0%, 5%, and 10%, for (A) adolescents, adults, and (B) infants. Utilities were 
calculated assuming the maximum amount of time traded could not exceed the duration of the health state
A. Adolescents and adults
Vaccination health states Disease health states
Local reaction Systemic reaction Mild cough Severe cough Pneumonia
Mean (SD) adolescent utilities 
for short-term TTO (N = 94)
0% 0.80 (0.32) 0.68 (0.36) 0.51 (0.39) 0.35 (0.38) 0.35 (0.37)
5% 0.95 (0.14) 0.92 (0.16) 0.87 (0.22) 0.80 (0.28) 0.80 (0.26)
10% 0.99 (0.03) 0.99 (0.04) 0.97 (0.08) 0.96 (0.11) 0.96 (0.08)
Mean (SD) adolescent utilities 
for long-term TTO (N = 81)
0% 0.96 (0.06) 0.92 (0.09) 0.88 (0.10) 0.82 (0.13) 0.82 (0.14)
5% 0.97 (0.07) 0.94 (0.11) 0.91 (0.12) 0.85 (0.18) 0.85 (0.17)
10% 0.99 (0.05) 0.97 (0.09) 0.95 (0.11) 0.91 (0.17) 0.91 (0.15)
Mean (SD) adult utilities 
for short-term TTO (N = 72)
0% 0.91 (0.24) 0.83 (0.29) 0.67 (0.38) 0.58 (0.42) 0.62 (0.40)
5% 0.97 (0.13) 0.96 (0.14) 0.90 (0.22) 0.88 (0.23) 0.88 (0.25)
10% 0.99 (0.04) 0.99 (0.04) 0.97 (0.07) 0.97 (0.08) 0.97 (0.08)
Mean (SD) adult utilities 
for long-term TTO (N = 56)
0% 0.99 (0.02) 0.97 (0.06) 0.93 (0.09) 0.88 (0.17) 0.88 (0.18)
5% 1.0 (0.01) 0.99 (0.03) 0.97 (0.05) 0.94 (0.13) 0.94 (0.15)
10% 1.0 (0.00) 1.0 (0.01) 0.99 (0.02) 0.97 (0.09) 0.96 (0.12)
B. Infants
Infant health states
Infant 
respiratory 
complications
Infant neurologic 
complications
Short-term TTO (N = 166)
0% 0.27 (0.36) 0.21 (0.33)
5% 0.71 (0.35) 0.66 (0.36)
10% 0.92 (0.17) 0.90 (0.19)
Long-term TTO (N = 147)
0% 0.36 (0.18) 0.33 (0.19)
5% 0.84 (0.21) 0.78 (0.26)
10% 0.89 (0.20) 0.84 (0.27)Health and Quality of Life Outcomes 2005, 3:17 http://www.hqlo.com/content/3/1/17
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the survey (22–27%), refused to answer the entire set of
questions (9–12%), or did not understand the exercise
(5–6%). We believe this may have been due in part to
respondent burden, because preference questions were
asked at the end of a lengthy cost interview. Also, we asked
both WTP and TTO questions for 7 separate health states.
In a separate analysis that included all answers to the set
of questions regardless of the level of understanding, we
found that the rank order of health states remained con-
sistent, which is reassuring.
Because of the complexity of the task required, it is not
surprising that respondents with higher educational levels
were more likely to complete and understand the prefer-
ences exercise. In addition, most respondents were white,
well educated, and had relatively high household
incomes. Household income was associated with utilities
as well as willingness-to-pay to avoid pertussis. To address
this limitation, economic analyses of pertussis should
vary willingness-to-pay and utilities over wide ranges that
would reflect the preferences of a general population. Fur-
ther research in more socioeconomically diverse popula-
tions should also be considered.
Another issue that should be explored more thoroughly is
the impact of parents as surrogate respondents for chil-
dren and the method of preference elicitation. We asked
parents of adolescents to serve as proxy respondents for
their child. Interestingly, parents of adolescents were less
likely to provide answers to the long-term TTO exercise
than adult respondents, which may suggest that parents
had difficulty answering the TTO question for long-term
illnesses in their children. Also, trading time from the par-
ent's life to avoid illness in a child may result in prefer-
ences that incorporate other aspects of their relationship
such as altruism. Previous work in the CV literature has
suggested that altruism may significantly affect valua-
tions. For example, Liu et al. found that a mother's WTP to
prevent a cold is approximately twice as large for the child
as for the mother[21]. While parents are often considered
to be the health care decision makers for their child, fur-
ther work on eliciting health state valuations directly from
children would provide useful information. In addition,
we asked parents how much time they would be willing to
give up from the end of their lives to avoid illness in their
child because we found that some parents refused to trade
time from their child's life whereas they were willing to
trade from their own life. Though this did not affect our
calculation of short-term utilities (since a common
denominator of 8 weeks was used), it did affect our
calculation of long-term utilities where the denominator
was based on the life expectancy of the child.
Conclusion
In this study, we estimated health-state valuations regard-
ing pertussis disease and vaccination among adult
patients and parents of adolescent patients. Patient
preferences in conjunction with health outcomes will be
key factors in deciding whether or not to implement a uni-
versal vaccination policy for adolescents or adults. The
results from our study suggest that short-term health-state
valuation may provide a reasonable approach to assessing
preferences given its superior ability to discriminate
between states, which may be particularly useful for cost-
utility analyses for future vaccination programs.
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